Actavis PLC

Find more results for NYSE:WPI

Officers and directors

Paul M. Bisaro
Executive Chairman of the Board
Brenton L. Saunders
President, Chief Executive Officer, Director
Maria Teresa Bernas Hilado
Chief Financial Officer
Robert A. Stewart
Chief Operating Officer
Jonathon Kellerman
Executive Vice President, Chief Compliance Officer
David A. Buchen
Executive Vice President - Commercial, North American Generics and International, Secretary
James C. D'Arecca
Chief Accounting Officer, Global
Patrick J. Eagan
Chief Human Resource Officer, Global
Charles M. Mayr
Chief Communication Officer, Global
Nesli Basgoz M.D.


70 Sir John Rogerson's Quay
DUBLIN, 07054
+353-21-65235000 (Phone)

Website links

Actavis PLC, is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In July 2014, the Company acquired Forest Laboratories, Inc. In July 2014, the Company acquired Furiex Pharmaceuticals, Inc. In July 2014, Impax Laboratories Inc acquired from Actavis plc two generic products.

Related companies

* Delayed by up to 20 minutes -  Disclaimer